y.mensah

TL3 Wiki editor · Accra, GH

Plain language editor. If a page needs a glossary to read the first paragraph, the first paragraph is wrong.

Joined 25 October 2024 · last posted 1d · groups: wiki-editors

156 posts, newest first. Showing up to 150.

Asking a follow-up: new topic or new reply? Replied, post #74 · Start Here › How to Ask · 27 Jul 2026 · 0 likes Adding a data point of agreement rather than a data point.
Seven-day rolling means and why weekly readings mislead Replied, post #101 · Outcomes › Progress reports · 24 Jul 2026 · 2 likes Post #99 is right about the mechanism and I think understates the practical bit. Self-reported intake is optimistic in a consistent direction, and saying so in your own…
What a reversed-phase purity number actually is Replied, post #89 · Analytics › HPLC & UHPLC · 24 Jul 2026 · 0 likes Post #86 describes the usual case. This is about the unusual one. A methods point on reversed-phase purity number rather than a substantive one: if the comparison is…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #54 · Practice › Interactions · 22 Jul 2026 · 9 likes The number people quote for Delayed gastric emptying and oral is a central estimate presented without its interval, and the interval is wide enough that the estimate is…
What a certificate commits its issuer to Replied, post #75 · Analytics › COA interpretation · 21 Jul 2026 · 27 likes Narrowing post #74, because the general version has more than one answer. An itemised related-substances table with retention times says considerably more about the…
Why the cheapest option is often not the cheapest Replied, post #21 · Access › Pricing · 19 Jul 2026 · 9 likes I read post #18 twice before replying, because I had assumed the opposite. Cheapest option is one of those subjects where the general answer and the answer for a…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #61 · Access › Insurance & coverage · 8 Jul 2026 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
Pooling trials with different estimands Replied, post #69 · Evidence › Meta-analyses · 4 Jul 2026 · 29 likes Taking post #68 at face value and following it one step further. An observation about pooling trials with different estimands that I cannot explain and am posting…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #85 · Start Here › Welcome · 1 Jul 2026 · 9 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Forced degradation studies: designing one that is informative Replied, post #88 · Analytics › Method validation · 30 Jun 2026 · 0 likes Specificity is the first question: does the method separate the analyte from everything reasonably expected to be present? A method that has not been challenged with…
Batch numbers that do not match the vial label Replied, post #36 · Sourcing › Red flags · 29 Jun 2026 · 0 likes An update on my earlier batch numbers post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
I joined for one answer and stayed for a year — what changed my mind Replied, post #50 · Start Here › Welcome · 29 Jun 2026 · 0 likes If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you.…
Retatrutide mass and identity: what a report should show Replied, post #5 · Compounds › Retatrutide · 27 Jun 2026 · 7 likes Post #4 answers the question as asked. The question underneath it is different. No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3…
About the Welcome category Replied, post #3 · Start Here › Welcome · 24 Jun 2026 · 0 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #109 · Sourcing › Logistics · 21 Jun 2026 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Small point, but it is the one…
Revisiting: What pooling buys you and what it destroys Replied, post #61 · Evidence › Meta-analyses · 20 Jun 2026 · 0 likes Right, and stated more narrowly than I would have dared to state it.
Spreadsheets: an appreciation — what changed since Replied, post #68 · Lounge › Off topic · 12 Jun 2026 · 0 likes An honest declaration on Spreadsheets: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #88 · Evidence › Journal club · 11 Jun 2026 · 9 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #63 · Practice › Storage & stability · 6 Jun 2026 · 12 likes What I would check first on reconstituted is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Second pass at: Programming during a large energy deficit Replied, post #14 · Nutrition & Training › Resistance training · 5 Jun 2026 · 5 likes Maintaining load with reduced volume is a reasonable strategy during a deficit and appears in the published literature more than the reverse. I would be glad to be…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #57 · Practice › Interactions · 4 Jun 2026 · 13 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
An appeal that succeeded, with the letter structure — the long version Replied, post #28 · Access › Insurance & coverage · 29 May 2026 · 11 likes What I would want before treating appeal as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #69 · Practice › Administration · 22 May 2026 · 32 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #9 · Compounds › Secretagogues & GH axis · 21 May 2026 · 1 like Whatever the answer on tesamorelin turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
A calculator that gives a right answer to the wrong question Replied, post #22 · Data & Tools › Calculators · 19 May 2026 · 6 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number.
Second pass at: A pooled estimate that changed when one trial was added Replied, post #8 · Evidence › Meta-analyses · 18 May 2026 · 9 likes For anyone finding this later: the short answer on pooled estimate is that it depends on one thing, and the rest of the thread is people identifying which thing.
Second pass at: Metformin co-administration and additive GI effects Replied, post #104 · Practice › Interactions · 13 May 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #50 · Compounds › Repair & healing peptides · 8 May 2026 · 14 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. Nothing in this subcategory is medical advice and several members here are…
Why the titration planner refuses to produce a schedule below a floor Replied, post #67 · Data & Tools › Calculators · 29 Apr 2026 · 3 likes Summarising the titration planner refuses thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it,…
Spreadsheets: an appreciation — what changed since Replied, post #24 · Lounge › Off topic · 21 Apr 2026 · 30 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that. Two…
Prediction intervals and why they are more honest than confidence intervals Replied, post #23 · Evidence › Meta-analyses · 10 Apr 2026 · 13 likes Narrowing post #21, because the general version has more than one answer. Double extraction with disagreement resolution is standard and is worth checking for, because…
Follow-up: State-level differences that actually matter Replied, post #80 · Regional › North America · 8 Apr 2026 · 2 likes On post #76 — agreed on the reasoning, with one qualification. State-level differences has been discussed here with more heat than it deserves, mostly because two…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #40 · Sourcing › Vendor reports · 24 Mar 2026 · 3 likes Building on post #39 rather than restating it. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps…
Preprint servers and what screening they do — the long version Replied, post #8 · Evidence › Preprints · 24 Mar 2026 · 16 likes Where I part company with post #4, and it is a narrow parting. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also…
Journal club: is percentage weight change the right endpoint? Replied, post #9 · Evidence › Journal club · 23 Mar 2026 · 17 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #100 · Clinical › Bloodwork · 14 Mar 2026 · 1 like Post #99 is right about the mechanism and I think understates the practical bit. Glycaemic markers integrate over different periods. A point glucose and a longer-term…
Peer-to-peer review: what actually happens on the call — one year on Replied, post #2 · Access › Insurance & coverage · 26 Feb 2026 · 0 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. A peer-to-peer review is available in many systems and is frequently more…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #6 · Sourcing › Logistics · 25 Feb 2026 · 2 likes Regional warehouse stock versus direct has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
Coming back to: Reading a supplier's product description as a marketing document Replied, post #24 · Compounds › Other compounds · 14 Feb 2026 · 29 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Mass error in ppm: the arithmetic and the caveat Replied, post #60 · Analytics › Mass spectrometry · 14 Feb 2026 · 7 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
Reconstitution volumes that produce round numbers, tabulated Replied, post #45 · Practice › Reconstitution · 13 Feb 2026 · 2 likes I had written a reply contradicting post #41 and deleted it. Here is what survived. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
Realistic expectations for strength while losing weight quickly Replied, post #60 · Nutrition & Training › Resistance training · 6 Feb 2026 · 0 likes On realistic expectations for strength: the maintained page in the documentation commons covers the general case with citations and a review date, which is more…
Trifluoroacetate content and its consequences Replied, post #74 · Analytics › Impurities & related substances · 3 Feb 2026 · 9 likes I had written a reply contradicting post #72 and deleted it. Here is what survived. Two questions I would want answered before drawing anything from the…
Run-in periods and the population they select Replied, post #57 · Evidence › Trials · 28 Jan 2026 · 1 like Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Lipase elevation without symptoms: the interpretation problem Replied, post #21 · Clinical › Bloodwork · 25 Jan 2026 · 19 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Reporting the observation and leaving the…
Pharmacy supply in the UK and the questions you will be asked Replied, post #17 · Regional › UK & Ireland · 22 Jan 2026 · 2 likes Availability through a private route and availability through the public system are separate questions and both change independently. Anyone with a larger sample,…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #2 · Outcomes › Progress reports · 20 Jan 2026 · 12 likes Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all change once loss stops.
A partial dose because the pen emptied mid-injection Replied, post #82 · Practice › Administration · 10 Jan 2026 · 7 likes Partial dose because the pen was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
A partial dose because the pen emptied mid-injection Replied, post #61 · Practice › Administration · 9 Jan 2026 · 0 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
Distinguishing expected GI effects from something that needs urgent attention Replied, post #50 · Practice › Side effects · 7 Jan 2026 · 19 likes Reflux and eructation are the two most under-reported effects in the first-hand accounts here, and both follow directly from delayed emptying. Not a strong opinion,…
Appeal templates and why they are deliberately unemotional Replied, post #30 · Access › Insurance & coverage · 7 Jan 2026 · 1 like Where I part company with post #28, and it is a narrow parting. A peer-to-peer review is available in many systems and is frequently more productive than a written…
The SOUL trial and oral semaglutide cardiovascular outcomes Started this topic · Compounds › Oral incretins · 7 Jan 2026 · 55 likes Posting this under the heading it deserves: The SOUL trial and oral semaglutide cardiovascular outcomes Everything below is what sits behind that. Collecting what is…
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #38 · Devices › Pens & autoinjectors · 3 Jan 2026 · 18 likes The residual left in a cartridge at the end is deliberate overfill and is not a dose you are entitled to extract. Attempting to recover it is where accuracy goes.
Journal club: LEADER as the historical anchor Replied, post #16 · Evidence › Journal club · 26 Dec 2025 · 3 likes On post #12 — agreed on the reasoning, with one qualification. Practical experience of LEADER, offered as one case with the conditions stated, not as a general finding.…
The decimal-point error, and the habit that catches it Replied, post #119 · Practice › Reconstitution · 18 Dec 2025 · 11 likes Answering the question post #118 raises rather than the one it answers. Preservative effectiveness is tested against a defined microbial challenge under defined…
[2026 update] Long-time reader, first-time poster Replied, post #34 · Lounge › Introductions · 18 Dec 2025 · 0 likes Welcome. Nobody will mind you asking something basic. The people most likely to answer are the ones who remember not knowing it.
Second pass at: What pooling buys you and what it destroys Replied, post #3 · Evidence › Meta-analyses · 18 Dec 2025 · 20 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Individual participant data pooling is a much stronger…
The decimal-point error, and the habit that catches it Replied, post #64 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. If anyone can…
Persistent vomiting and the threshold for seeking help Replied, post #86 · Safety › Adverse events · 11 Dec 2025 · 4 likes The published trial rates come from supervised populations on defined schedules and are not comparable to rates derived from who chooses to post.
Documentation that materially improves an appeal's chances Replied, post #99 · Access › Insurance & coverage · 11 Dec 2025 · 7 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #4 · Practice › Storage & stability · 7 Dec 2025 · 0 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Tirzepatide's shorter half-life and its one practical consequence Replied, post #22 · Compounds › Tirzepatide · 5 Dec 2025 · 0 likes Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth knowing about rather than worth alarm — and it is one of the…
Dead volume across syringe and needle combinations Replied, post #33 · Devices › Syringes & needles · 4 Dec 2025 · 3 likes I would call the community position on dead volume across syringe likely rather than established, and I would be comfortable defending that hedge.
Personal import allowances, compared — a second dataset Replied, post #30 · Access › International · 2 Dec 2025 · 19 likes I would be cautious about generalising from the Personal import allowances example above. It is a good example. It is one example.
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #49 · Analytics › Impurities & related substances · 24 Nov 2025 · 5 likes Picking up post #47: that is the part I would want checked first. I changed my mind about Aggregates after someone here asked me for the source and I could not produce…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #28 · Practice › Reconstitution · 24 Nov 2025 · 11 likes Post #26 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL…
Non-inferiority margins: how they are chosen and how they are abused Replied, post #17 · Evidence › Trials · 22 Nov 2025 · 0 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. Reframing non-inferiority margins slightly, because I think the disagreement is…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #98 · Practice › Reconstitution · 13 Nov 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Stepping down deliberately, and how to do it without losing progress Replied, post #13 · Practice › Dosing & titration · 10 Nov 2025 · 0 likes Post #11 is right about the mechanism and I think understates the practical bit. Stepping down deliberately: the withdrawal trials show that stopping is followed by…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #40 · Compounds › Semaglutide · 4 Nov 2025 · 3 likes I read post #36 twice before replying, because I had assumed the opposite. Semaglutide half-life: I would want to see the raw numbers rather than the summary before…
Temperature loggers worth the money — the long version Replied, post #67 · Devices › Cold chain · 2 Nov 2025 · 0 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.…
Sleep tracking data and its considerable limitations Replied, post #85 · Wellbeing › Sleep · 25 Oct 2025 · 8 likes Post #82 and I disagree about the size of the effect, not about the direction. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The timeframe…
Payment mechanics and the recovery options that do not exist Replied, post #39 · Sourcing › Payments · 20 Oct 2025 · 12 likes The site does not carry prices, payment details or transaction routes, and questions asking for them will be answered with that rather than with a link. A guess,…
New subcategory: rationale and scope Replied, post #67 · Meta › Announcements · 20 Oct 2025 · 6 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
Tracking that stops updating and then resumes — the long version Replied, post #27 · Sourcing › Logistics · 18 Oct 2025 · 9 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #46 · Start Here › Welcome · 16 Oct 2025 · 30 likes Worth knowing early: the archive is not retrospectively corrected. A topic from two years ago was accurate when written and may not be now. Every post carries its date…
Reading an interaction checker output critically Replied, post #21 · Practice › Interactions · 13 Oct 2025 · 6 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. A pharmacist can answer most questions in this subcategory in a few minutes with…
A preprint whose numbers changed substantially at publication Replied, post #87 · Evidence › Preprints · 11 Oct 2025 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
Compounds this community declines to help with, and why Replied, post #67 · Compounds › Other compounds · 5 Oct 2025 · 23 likes Post #64 describes the usual case. This is about the unusual one. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #14 · Evidence › Preprints · 26 Sep 2025 · 29 likes Coming back to post #10, because the follow-up matters more than the original answer. Author track record is a weak signal and it is a signal. A group that has…
Compounds this community declines to help with, and why Replied, post #16 · Compounds › Other compounds · 26 Sep 2025 · 14 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #5 · Practice › Storage & stability · 25 Sep 2025 · 10 likes Checked the Storing lyophilised material long term claim against the primary source this morning. It survives, with a narrower scope than the version quoted here.…
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #41 · Evidence › Study critique · 13 Sep 2025 · 25 likes Reverse causation looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #41 · Analytics › HPLC & UHPLC · 1 Sep 2025 · 2 likes On detection wavelength the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Particulates in a reconstituted solution: identifying the likely source Replied, post #4 · Analytics › Impurities & related substances · 28 Aug 2025 · 3 likes A request rather than an answer: could whoever has the primary source for particulates post it? I have seen the claim three times this month and each version had lost a…
Enforcement priorities versus written rules — does this still hold? Replied, post #32 · Sourcing › Regulatory · 27 Aug 2025 · 29 likes Taking post #31 at face value and following it one step further. Import rules for personal quantities differ from commercial import rules and both differ by country.…
Are there stupid questions here? A staff answer, at length Replied, post #95 · Start Here › Welcome · 21 Aug 2025 · 9 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
[2026 update] US compounding rules and how they changed Replied, post #32 · Regional › North America · 18 Aug 2025 · 0 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. Where I…
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #47 · Evidence › Journal club · 16 Aug 2025 · 16 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
Are there stupid questions here? A staff answer, at length Replied, post #76 · Start Here › Welcome · 15 Aug 2025 · 1 like On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #10 · Evidence › Journal club · 10 Aug 2025 · 22 likes This is the first time the answer has come with its own limits attached. Appreciated.
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #22 · Compounds › Tirzepatide · 3 Aug 2025 · 2 likes Post #18 describes the usual case. This is about the unusual one. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
Coming back to: When "no data" is the complete and final answer Replied, post #67 · Compounds › Other compounds · 1 Aug 2025 · 13 likes That matches what I have seen, for whatever a single anecdote is worth.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #61 · Access › Insurance & coverage · 29 Jul 2025 · 0 likes That is a cleaner way of putting what I was circling around.
A field-by-field walk through a certificate of analysis Replied, post #49 · Analytics › COA interpretation · 15 Jul 2025 · 11 likes I would call the community position on field-by-field walk through a certificate likely rather than established, and I would be comfortable defending that hedge.
How to read a forest plot, properly, from scratch Replied, post #5 · Evidence › Trials · 13 Jul 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
Checking someone else's arithmetic: a worked example thread Replied, post #66 · Practice › Reconstitution · 11 Jul 2025 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
Antibiotics and a course of something with delayed emptying Replied, post #87 · Practice › Interactions · 10 Jul 2025 · 31 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
Coming back to: When "no data" is the complete and final answer Replied, post #23 · Compounds › Other compounds · 24 Jun 2025 · 29 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
A report I filed that turned out to be wrong, and the correction Replied, post #114 · Sourcing › Vendor reports · 21 Jun 2025 · 5 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. Worth saying I have only my…
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #22 · Compounds › Semaglutide · 10 Jun 2025 · 23 likes A note on how Semaglutide half-life gets discussed rather than on Semaglutide half-life itself: the confident posts get the replies and the careful ones get ignored,…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #36 · Devices › Cold chain · 7 Jun 2025 · 0 likes Airline travel would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #25 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 5 likes Answering the question post #21 raises rather than the one it answers. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #7 · Sourcing › Vendor reports · 30 May 2025 · 0 likes Picking up post #6: that is the part I would want checked first. The cost of a submission is worth stating. It is the main reason people do not do this and knowing the…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #58 · Wellbeing › Mental health · 26 May 2025 · 30 likes The arithmetic in post #55 is right; the assumption feeding it is the part to check. Where I would push back on the history of disordered eating consensus is the…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #57 · Practice › Reconstitution · 23 May 2025 · 14 likes 10 mg vial reconstituted three has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here…
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #48 · Compounds › Repair & healing peptides · 21 May 2025 · 4 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
Travel coolers and how long they really hold — the long version Replied, post #13 · Devices › Cold chain · 21 May 2025 · 33 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. Travel with medication: carrying a vial across borders requires planning if…
Pregnancy as an absolute contraindication Replied, post #38 · Safety › Contraindications · 18 May 2025 · 11 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #19 · Evidence › Journal club · 17 Apr 2025 · 27 likes STEP 1 was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #5 · Practice › Dosing & titration · 11 Apr 2025 · 13 likes Coming back to post #3, because the follow-up matters more than the original answer. Reaching a dose and staying there for a year: the question of whether a stable dose…
When to suspect the method rather than the sample Replied, post #112 · Analytics › Method validation · 10 Apr 2025 · 29 likes Range and working range are different things and a certificate rarely distinguishes them. The relevant one is the range over which this particular sample was measured.
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #17 · Compounds › Retatrutide · 8 Apr 2025 · 0 likes Worth separating Retatrutide mass and identity as a question about the compound from Retatrutide mass and identity as a question about the documentation. They get…
Review: a draft on reconstitution arithmetic, with objections Replied, post #75 · Documentation › Doc review · 26 Mar 2025 · 0 likes Objections are genuinely wanted at this stage, because a bad promotion is much harder to undo than a bad reply.
Adjudicated events and why the definition matters — the long version Replied, post #64 · Evidence › Trials · 25 Mar 2025 · 2 likes Post #61 is the version of this I will quote in future. One addition. Absolute and relative effects answer different questions. Write down the event rate in each arm…
Why cagrilintide alone is discussed so much less than in combination Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 24 Mar 2025 · 6 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
Why cagrilintide alone is discussed so much less than in combination Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 0 likes The phase 3 combination programme is where the clinically interesting numbers will come from. Phase 2 established that the combination does something; the size of it in…
Coverage for the indication versus for the drug — a second dataset Replied, post #33 · Access › Insurance & coverage · 21 Mar 2025 · 0 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. If the premise is wrong,…
Journal club: SURMOUNT-1, read without the press release Replied, post #81 · Evidence › Journal club · 20 Mar 2025 · 2 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #128 · Sourcing › Vendor reports · 18 Mar 2025 · 0 likes The cost of a submission is worth stating. It is the main reason people do not do this and knowing the figure helps somebody else decide. I am describing what is,…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #122 · Pharmacology › Receptor biology · 18 Mar 2025 · 19 likes Post #119 is right about the mechanism and I think understates the practical bit. GIP receptor biology is genuinely contested. Both agonism and antagonism have been…
Adducts: sodium, potassium, and the peak you did not expect Replied, post #33 · Analytics › Mass spectrometry · 13 Mar 2025 · 0 likes Trifluoroacetate adducts are common in material purified with TFA and are one reason a mass spectrum from a peptide can look busier than expected. The answer changed…
Retatrutide dose escalation in the published trials Replied, post #3 · Compounds › Retatrutide · 10 Mar 2025 · 24 likes Duration is the other limitation. The published exposure is measured in months, and the questions people are actually asking are about years.
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #29 · Evidence › Journal club · 7 Mar 2025 · 16 likes Nothing to add on the substance. Thank you for taking the question at face value.
Research-use-only status: what it means legally and practically — a second dataset Replied, post #106 · Compounds › Other compounds · 5 Mar 2025 · 2 likes That is consistent with mine, for whatever one more account is worth.
Charge states for a 4 kDa peptide, worked through Replied, post #7 · Analytics › Mass spectrometry · 2 Mar 2025 · 13 likes That is a cleaner way of putting what I was circling around.
Why quantitation is the hard part, not detection Replied, post #6 · Analytics › Home & field testing · 23 Feb 2025 · 0 likes I disagree with the framing of quantitation above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #96 · Compounds › Other compounds · 22 Feb 2025 · 14 likes Research-use-only status: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #131 · Evidence › Journal club · 17 Feb 2025 · 9 likes What I can speak to on SURPASS-2 is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #83 · Sourcing › Regulatory · 12 Feb 2025 · 0 likes Two questions I would want answered before drawing anything from the Research-use-only labelling data above: how were the cases selected, and what happened to the ones…
Triple agonism: additive, synergistic, or neither? Replied, post #16 · Compounds › Retatrutide · 5 Feb 2025 · 8 likes The bit of triple agonism that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
When "no data" is the complete and final answer Replied, post #80 · Compounds › Other compounds · 31 Jan 2025 · 17 likes That is the distinction I keep failing to hold on to. Written down now.
Transit times by route, from a logged dataset — the long version Replied, post #53 · Sourcing › Logistics · 26 Jan 2025 · 4 likes The honest answer on Transit times is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #104 · Evidence › Journal club · 25 Jan 2025 · 18 likes Marking my place. If it changes for me I will come back and say so.
Second pass at: Regression to the mean in progress reports Replied, post #24 · Research Methods › Statistics · 14 Jan 2025 · 16 likes Speaking only to Regression as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
[2026 update] New subcategory: rationale and scope Replied, post #92 · Meta › Announcements · 25 Dec 2024 · 0 likes Understood, and I withdraw the assumption I opened with.
Persistent vomiting and the threshold for seeking help — one year on Replied, post #44 · Safety › Adverse events · 23 Dec 2024 · 0 likes Adding the measurement that post #43 says would settle it. What I can speak to on Persistent vomiting is narrow, so I will keep it narrow rather than generalising from…
Asking about a compound your prescriber has not heard of — one year on Replied, post #16 · Clinical › Prescriber conversations · 13 Dec 2024 · 0 likes Write the questions down in advance and put the most important one first. Appointments end and the order is what decides which questions get answered. I would be glad…
Injection-site reactions: describing them precisely enough to be useful Replied, post #64 · Practice › Side effects · 11 Dec 2024 · 0 likes Post #61 answers the question as asked. The question underneath it is different. The relationship between symptom burden and outcome is not what people assume. Feeling…
Training through a dose escalation week Replied, post #3 · Nutrition & Training › Resistance training · 18 Nov 2024 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Protein and training are complements rather than alternatives, and the published work…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #35 · Compounds › Repair & healing peptides · 11 Nov 2024 · 25 likes Anecdote is the whole of the human evidence base here, and this community's convention is to say so rather than to aggregate anecdotes into something that sounds like…
People with a low starting BMI: where the evidence stops Replied, post #12 · Clinical › Special populations · 2 Nov 2024 · 32 likes Post #10 answers the question as asked. The question underneath it is different. Adolescent evidence exists for some compounds in this class and is a separate approval…
A page that has drifted out of date and needs a maintainer Replied, post #24 · Documentation › Wiki requests · 1 Nov 2024 · 0 likes Scope the request narrowly. A page about one thing gets written and stays current; a page about a field does not. This is the sort of thing that ought to be settled and…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #2 · Compounds › Tirzepatide · 17 Oct 2024 · 2 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #82 · Practice › Dosing & titration · 13 Oct 2024 · 0 likes My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
Second pass at: Hoarding and why it makes a shortage worse Replied, post #73 · Access › Shortages · 11 Oct 2024 · 0 likes Post #72 answers the question as asked. The question underneath it is different. A shortage of one presentation is not a shortage of all of them, and the published…
Requesting a page: what makes a good request — what changed since Replied, post #50 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Helpful, and short, which on this subject is harder than long.
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #19 · Practice › Side effects · 9 Oct 2024 · 5 likes Answering the question post #17 raises rather than the one it answers. Small correction to my own earlier position on nausea timeline. I had the units the wrong way…
SURPASS-2 and the comparator dose question that will not go away Replied, post #14 · Compounds › Tirzepatide · 11 Sep 2024 · 19 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #51 · Analytics › COA interpretation · 10 Sep 2024 · 0 likes The claim about field-by-field walk through a certificate upthread is stronger than its source supports. I have read the source. The source says "associated with" and…